• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Biocon Limited — Updates, 26-08-2025: General Updates

    26-08-2025 | 08:58 pm

    Biocon's subsidiary secured tentative approval for Sitagliptin tablets, a diabetes drug, for the US market. This move strengthens the company's drug portfolio and future growth prospects.

    No comments yet. Be the first to comment!

    All announcements from Biocon Limited